Multiple Myeloma Research Foundation (MMRF) Announces $15 Million Investment In Immunotherapy Initiative Post author:Sam Post published:June 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Bio-Rad to Shut Down Cambridge R&D Site in Consolidation October 8, 2017 <b>ManaMed</b> Introduces PlasmaFlow, The World's First FDA-Approved Digital And Tubeless Deep Vein Thrombosis Prevention Device September 20, 2017 More Deaths Lead Seattle Genetics to Discontinue Phase III Leukemia Study June 18, 2017
<b>ManaMed</b> Introduces PlasmaFlow, The World's First FDA-Approved Digital And Tubeless Deep Vein Thrombosis Prevention Device September 20, 2017